Amalgamated Bank Aclaris Therapeutics, Inc. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.92 - $1.44 $6,891 - $10,787	-7,491 Reduced 76.45%	2,307 $3,000
Q4 2023 Feb 06, 2024	SELL	$0.64 - $6.49 $439 - $4,452	-686 Reduced 6.54%	9,798 $10,000
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $10,935 - $14,747	1,386 Added 15.23%	10,484 $108,000
Q1 2023 May 02, 2023	SELL	$7.07 - $17.95 $9,579 - $24,322	-1,355 Reduced 12.96%	9,098 $74,000
Q3 2022 Nov 09, 2022	BUY	$13.07 - $18.22 $13,083 - $18,238	1,001 Added 10.59%	10,453 $165,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $11,643 - $19,573	1,146 Added 13.8%	9,452 $132,000
Q1 2022 Jun 30, 2022	BUY	$9.74 - $17.92 $80,900 - $148,843	8,306 New	8,306 $143,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.